[Federal Register Volume 63, Number 175 (Thursday, September 10, 1998)]
[Notices]
[Page 48522]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-24297]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on June 10, 1998, Dupont 
Pharmaceuticals, The Dupont Merck Pharmaceutical Co., 1000 Stewart 
Avenue, Garden City, New York 11530, made application by renewal to the 
Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Oxycodone (9143)...........................  II                         
Hydrocodone (9193).........................  II                         
Oxymorphone (9652).........................  II                         
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
make finished products.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than (60 days from publication).

    Dated: September 2, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-24297 Filed 9-9-98; 8:45 am]
BILLING CODE 4410-09-M